Corrections and Clarifications


+ See all authors and affiliations

Science  08 May 1987:
Vol. 236, Issue 4802, pp. 657
DOI: 10.1126/science.236.4802.657-a


In Table 1 (p. 897) of the report "Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo" by John W. Greiner et al. (20 Feb., p. 895), the first value under the heading "Plasma Hu-IFN-αA level (antiviral unit/ml)" should have been <30.